TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,740 | -26.2% | 37,443 | +26.8% | 0.00% | – |
| Q2 2023 | $453,412 | -18.1% | 29,519 | +19.9% | 0.00% | – |
| Q1 2023 | $553,906 | +7.7% | 24,629 | +0.7% | 0.00% | – |
| Q4 2022 | $514,394 | -96.2% | 24,460 | -95.5% | 0.00% | -100.0% |
| Q3 2022 | $13,398,961 | +1.6% | 543,789 | -0.1% | 0.01% | 0.0% |
| Q2 2022 | $13,188,219 | -5.9% | 544,293 | +0.0% | 0.01% | 0.0% |
| Q1 2022 | $14,020,065 | -16.9% | 544,046 | -1.0% | 0.01% | -10.0% |
| Q4 2021 | $16,871,000 | -1.4% | 549,488 | -22.2% | 0.01% | -28.6% |
| Q3 2021 | $17,119,000 | +65.4% | 705,925 | -0.5% | 0.01% | +75.0% |
| Q2 2021 | $10,351,000 | -82.1% | 709,502 | -69.3% | 0.01% | -84.0% |
| Q1 2021 | $57,678,000 | -3.2% | 2,309,887 | +5.6% | 0.05% | -9.1% |
| Q4 2020 | $59,603,000 | – | 2,186,830 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |